Pieter Evenepoel
#152,661
Most Influential Person Now
Researcher
Pieter Evenepoel's AcademicInfluence.com Rankings
Pieter Evenepoelcomputer-science Degrees
Computer Science
#8147
World Rank
#8569
Historical Rank
Machine Learning
#3249
World Rank
#3288
Historical Rank
Artificial Intelligence
#3555
World Rank
#3605
Historical Rank
Database
#5180
World Rank
#5380
Historical Rank
Download Badge
Computer Science
Why Is Pieter Evenepoel Influential?
(Suggest an Edit or Addition)Pieter Evenepoel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. (2004) (1045)
- Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. (2017) (658)
- Uremic toxins originating from colonic microbial metabolism. (2009) (361)
- Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. (2006) (350)
- Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. (2004) (280)
- Free p-cresol is associated with cardiovascular disease in hemodialysis patients. (2008) (270)
- Oxidative Stress in Chronic Kidney Disease (2016) (263)
- p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. (2010) (256)
- Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. (2016) (255)
- p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. (2010) (253)
- Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure (2006) (244)
- Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. (2004) (235)
- The uremic retention solute p-cresyl sulfate and markers of endothelial damage. (2009) (223)
- Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney DiseaseMineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update (2018) (213)
- Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. (1997) (207)
- The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. (2011) (199)
- Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea (2003) (178)
- Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. (2003) (177)
- Adjuvant Low‐Dose Cidofovir Therapy for BK Polyomavirus Interstitial Nephritis in Renal Transplant Recipients (2005) (176)
- Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. (2005) (171)
- Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long‐term Pharmacokinetics in de Novo Renal Allograft Recipients (2004) (162)
- The gut–kidney axis (2017) (159)
- Tertiary ‘Hyperphosphatoninism’ Accentuates Hypophosphatemia and Suppresses Calcitriol Levels in Renal Transplant Recipients (2007) (153)
- Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients (2008) (152)
- Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. (2004) (150)
- Sclerostin: Another vascular calcification inhibitor? (2013) (149)
- Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. (2008) (144)
- p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. (2009) (144)
- Intrarenal resistive index after renal transplantation. (2013) (144)
- Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. (2001) (139)
- Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference. (2015) (129)
- Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. (2005) (129)
- Digestibility of cooked and raw egg protein in humans as assessed by stable isotope techniques. (1998) (124)
- Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? (2013) (121)
- A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. (2004) (120)
- High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. (2015) (119)
- Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. (2005) (118)
- The Histology of Kidney Transplant Failure: A Long-Term Follow-Up Study (2014) (114)
- Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. (2016) (113)
- Time-Related Clinical Determinants of Long-Term Tacrolimus Pharmacokinetics in Combination Therapy with Mycophenolic Acid and Corticosteroids (2004) (113)
- Sclerostin and DKK1: new players in renal bone and vascular disease. (2015) (112)
- Long‐Term Changes in Mycophenolic Acid Exposure in Combination with Tacrolimus and Corticosteroids Are Dose Dependent and Not Reflected by Trough Plasma Concentration: A Prospective Study in 100 De Novo Renal Allograft Recipients (2003) (112)
- The gut microbiota metabolite indole alleviates liver inflammation in mice (2018) (112)
- Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. (2006) (110)
- Evidence for impaired assimilation of protein in chronic renal failure. (2003) (109)
- Surgical Treatment of Persistent Hyperparathyroidism After Renal Transplantation (2008) (106)
- A review of albumin binding in CKD. (2008) (106)
- The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. (2014) (106)
- Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. (2010) (106)
- Parathyroid hormone metabolism and signaling in health and chronic kidney disease. (2016) (104)
- Intestinal microbiome and fitness in kidney disease (2019) (102)
- Albumin is the main plasma binding protein for indoxyl sulfate and p‐cresyl sulfate (2013) (101)
- Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. (2017) (99)
- Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial (2012) (99)
- Renal safety in patients treated with bisphosphonates for osteoporosis: A review (2013) (96)
- The Influence of CKD on Colonic Microbial Metabolism. (2015) (96)
- Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. (2006) (96)
- Amount and fate of egg protein escaping assimilation in the small intestine of humans. (1999) (95)
- Parathyroidectomy after successful kidney transplantation: a single centre study. (2007) (95)
- Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance. (2019) (93)
- Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. (2013) (89)
- Detoxifying Capacity and Kinetics of Prometheus® – A New Extracorporeal System for the Treatment of Liver Failure (2005) (83)
- Warning: the unfortunate end of p-cresol as a uraemic toxin. (2011) (83)
- In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. (1998) (82)
- Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. (2004) (82)
- Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy. (1999) (81)
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. (2010) (81)
- Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. (2013) (81)
- Food as medicine: targeting the uraemic phenotype in chronic kidney disease (2020) (80)
- A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism (2014) (79)
- Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). (2008) (78)
- Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients. (2005) (78)
- Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. (2008) (76)
- The value of tuberculin skin testing in haemodialysis patients. (2004) (76)
- The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites (2015) (74)
- The Colon: An Overlooked Site for Therapeutics in Dialysis Patients (2013) (74)
- Intestinal Barrier Function in Chronic Kidney Disease (2018) (70)
- Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. (2007) (69)
- Calcium metabolism in the early posttransplantation period. (2009) (69)
- Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results. (1998) (69)
- Review article: non‐biological liver support in liver failure (2006) (68)
- Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. (2004) (66)
- The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial (2016) (65)
- Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. (2009) (64)
- Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? (2014) (63)
- European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D. (2020) (63)
- Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. (2009) (63)
- Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption. (2007) (63)
- Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study. (2006) (61)
- From skeletal to cardiovascular disease in 12 steps—the evolution of sclerostin as a major player in CKD-MBD (2016) (61)
- Chronic Histological Damage in Early Indication Biopsies Is an Independent Risk Factor for Late Renal Allograft Failure (2013) (61)
- Major Coagulation Disturbances During Fractionated Plasma Separation and Adsorption (2007) (59)
- Differential Effect of Diarrhea on FK506 Versus Cyclosporine A Trough Levels and Resultant Prevention of Allograft Rejection in Renal Transplant Recipients (2002) (58)
- Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study. (2016) (58)
- Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. (2002) (57)
- Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome (2013) (57)
- The use of an anti‐CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low‐dose tacrolimus and early withdrawal of steroids in renal transplant recipients (2003) (56)
- Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. (2015) (56)
- Calcium Requirements after Parathyroidectomy in Patients with Refractory Secondary Hyperparathyroidism (2008) (56)
- Late referral of patients with chronic kidney disease: no time to waste. (2006) (54)
- Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients. (2015) (53)
- Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD. (2015) (53)
- Localization, Etiology and Impact of Calcium Phosphate Deposits in Renal Allografts (2009) (52)
- A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters (2001) (52)
- The influence of inulin on the absorption of nitrogen and the production of metabolites of protein fermentation in the colon (2006) (51)
- Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. (2019) (51)
- Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies (2016) (50)
- Production of egg proteins, enriched with L-leucine-13C1, for the study of protein assimilation in humans using the breath test technique. (1997) (49)
- Circulating markers of bone turnover (2017) (49)
- Pro: cardiovascular calcifications are clinically relevant. (2015) (49)
- Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative—a position paper (2017) (47)
- Romosozumab in postmenopausal women with osteopenia. (2014) (47)
- Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? (2016) (47)
- Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System (2003) (46)
- Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD. (2016) (46)
- Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease (2014) (45)
- C3D DEPOSITION IN PERITUBULAR CAPILLARIES INDICATES A VARIANT OF ACUTE RENAL ALLOGRAFT REJECTION CHARACTERIZED BY A WORSE CLINICAL OUTCOME (2003) (45)
- The Effect of Anastomosis Time on Outcome in Recipients of Kidneys Donated After Brain Death: A Cohort Study (2015) (44)
- Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease (2020) (44)
- A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis. (2002) (43)
- Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement? (1998) (42)
- Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End‐Stage Renal Disease (2018) (41)
- Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients. (2012) (41)
- Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss. (2010) (40)
- Calcimimetics in chronic kidney disease: evidence, opportunities and challenges. (2008) (40)
- Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study (2010) (39)
- Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it! (2019) (39)
- Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD (2017) (38)
- Dietary fiber and protein: nutritional therapy in chronic kidney disease and beyond. (2012) (38)
- Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation. (2017) (38)
- A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System (2012) (37)
- Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial (2017) (37)
- Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipients (2013) (36)
- A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. (2008) (36)
- 13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine (2000) (36)
- Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl. (2009) (36)
- Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient. (2005) (35)
- A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism. (2016) (35)
- Invasive aspergillosis after kidney transplant: case-control study. (2015) (34)
- Acute toxic renal failure. (2004) (33)
- Bone-Vascular Axis in Chronic Kidney Disease. (2019) (33)
- Update on the role of bone biopsy in the management of patients with CKD–MBD (2017) (32)
- Alteration in digestion and absorption of nutrients during profound acid suppression. (2001) (32)
- Inflammation and the bone-vascular axis in end-stage renal disease (2016) (31)
- Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease (2018) (31)
- Another devastating complication of the Schnitzler syndrome: AA amyloidosis (2007) (31)
- Heritability and Clinical Determinants of Serum Indoxyl Sulfate and p-Cresyl Sulfate, Candidate Biomarkers of the Human Microbiome Enterotype (2014) (31)
- Uremia Suppresses Immune Signal-Induced CYP27B1 Expression in Human Monocytes (2012) (31)
- The influence of renal transplantation on retained microbial-human co-metabolites. (2016) (31)
- A Prospective, Randomized, Double-Blind Crossover Study on the Use of 5% Citrate Lock versus 10% Citrate Lock in Permanent Hemodialysis Catheters (2005) (29)
- Gastric emptying flow curves separated from carbon-labeled octanoic acid breath test results. (1998) (29)
- Biomarkers Predicting Bone Turnover in the Setting of CKD (2017) (29)
- THE RATE OF GASTRIC EMPTYING DETERMINES THE TIMING BUT NOT THE EXTENT OF ORAL TACROLIMUS ABSORPTION: SIMULTANEOUS MEASUREMENT OF DRUG EXPOSURE AND GASTRIC EMPTYING BY CARBON-14-OCTANOIC ACID BREATH TEST IN STABLE RENAL ALLOGRAFT RECIPIENTS (2004) (29)
- Validation of lactose[15N,15N]ureide as a tool to study colonic nitrogen metabolism. (2005) (29)
- Validation of a new test meal for a protein digestion breath test in humans. (2004) (26)
- Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients. (2016) (26)
- Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. (2006) (26)
- Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. (2021) (26)
- 'Full house' positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt. (2001) (26)
- Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease (2018) (25)
- Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients. (2010) (25)
- Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function (2014) (24)
- Amount and fate of egg protein escaping assimilation in the small intestine of humans. (1999) (24)
- Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab? (2007) (24)
- Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism (2016) (23)
- Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS (2020) (23)
- In vivo evaluation of a colonic delivery system using isotope techniques (2005) (23)
- Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know (2018) (23)
- Long‐Term Pharmacokinetic Study of the Novel Combination of Tacrolimus and Sirolimus in De Novo Renal Allograft Recipients (2003) (22)
- Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation. (2005) (22)
- A balanced view of calcium and phosphate homeostasis in chronic kidney disease. (2013) (21)
- Data Sharing Under the General Data Protection Regulation (2021) (21)
- Heparin-coated dialyzer membranes: is non-inferiority good enough? (2014) (20)
- Reduction in Protein-Bound Solutes Unacceptable as Marker of Dialysis Efficacy during Alternate-Night Nocturnal Hemodialysis (2011) (20)
- p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky. (2017) (20)
- Combined Kidney and Intestinal Transplantation in Patients With Enteric Hyperoxaluria Secondary to Short Bowel Syndrome (2013) (20)
- Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients. (2002) (20)
- Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol. (2018) (20)
- Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy. (2001) (20)
- The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven. (2002) (19)
- Evidence in Favor of a Severely Impaired Net Intestinal Calcium Absorption in Patients with (Early-Stage) Chronic Kidney Disease (2012) (19)
- Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation. (2013) (19)
- Sclerostin deficiency modifies the development of CKD-MBD in mice. (2018) (19)
- AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis. (2021) (19)
- Magnesium-based interventions for normal kidney function and chronic kidney disease. (2016) (18)
- A distinct bone phenotype in ADPKD patients with end-stage renal disease. (2019) (17)
- Troponin I Is a Predictor of Acute Cardiac Events in the Immediate Postoperative Renal Transplant Period (2010) (17)
- Bone evaluation in paediatric chronic kidney disease: Clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA. (2020) (17)
- Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. (2021) (17)
- Prevalence and determinants of anemia in the immediate postkidney transplant period (2011) (16)
- Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function (2015) (15)
- The Role of Gut Dysbiosis in the Bone–Vascular Axis in Chronic Kidney Disease (2020) (15)
- Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient. (2005) (15)
- Effect of Dietary Inulin Supplementation on the Gut Microbiota Composition and Derived Metabolites of Individuals Undergoing Hemodialysis: A Pilot Study. (2021) (15)
- Death with functioning graft--a preventable cause of graft loss. (2001) (15)
- A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study (2017) (15)
- Daytime Rhythm and Treatment-Related Fluctuations of Serum Phosphorus Concentration in Dialysis Patients (2012) (15)
- Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial (2017) (14)
- Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease (2019) (14)
- Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patients. (2016) (14)
- Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients (2003) (14)
- Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet) (2015) (14)
- The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B. (2001) (14)
- 1β,25-Dihydroxyvitamin D3: A new vitamin D metabolite in human serum (2017) (14)
- A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients. (2005) (14)
- Postimplantation X-ray parameters predict functional catheter problems in peritoneal dialysis. (2014) (13)
- The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin‐bound toxins (2005) (13)
- Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients (2019) (13)
- Traditional and Non-traditional Risk Factors for Osteoporosis in CKD (2021) (13)
- Oral cinacalcet HCI (AMG 073) for the treatment of hemodialysis patients with secondary hyperparathyroidism (HPT): Results of a European/Australian-Phase 3 study (2003) (13)
- The Bone after Kidney Transplantation. (2019) (13)
- PTH, FGF23, and calcium: it takes three to tango? (2011) (12)
- Control of hyperphosphatemia beyond phosphate. (2007) (12)
- Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey (2020) (12)
- Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients (2020) (12)
- Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction? (2020) (11)
- Impact of Vascular Calcification on Corrected QT Interval at the Time of Renal Transplantation (2011) (11)
- Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney Disease (2017) (11)
- Microscopic nephrocalcinosis in chronic kidney disease patients. (2015) (11)
- Opponent's comments. (2015) (11)
- Vitamin K in CKD Bone Disorders (2021) (11)
- Prometheus versus MARS: Comparison of efficiency in two different liver detoxification devices (2005) (11)
- Calcium balance in chronic kidney disease: walking the tightrope. (2012) (11)
- Quantitative histomorphometric analysis of halved iliac crest bone biopsies yield comparable ROD diagnosis as full 7.5 mm wide samples. (2020) (11)
- Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. (2005) (10)
- The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research (2019) (10)
- Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation. (2014) (10)
- Facing cinacalcet-induced hypocalcemia: sit back and relax? (2018) (10)
- The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation (2020) (10)
- A microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy (2020) (10)
- The fate of triaged and rejected manuscripts. (2015) (9)
- Magnesium chloride slows gastric emptying, but does not affect digestive functions (2002) (9)
- Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism (2021) (9)
- Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees (2020) (9)
- Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study (2021) (9)
- Recipient-derived chronic lymphocytic leukaemia diagnosed shortly after kidney transplantation on protocol biopsy. (2009) (8)
- Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis. (2012) (8)
- Dietary phosphorus restriction in predialysis chronic kidney disease: time for a cease-fire? (2016) (8)
- Patterns of renal osteodystrophy one year after kidney transplantation. (2021) (8)
- Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements. (2010) (7)
- Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene? (2017) (7)
- Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease. (2021) (7)
- Bone biomarkers in de novo renal transplant recipients. (2019) (7)
- Calcium metabolism in the early post-transplant period. (2011) (7)
- Quantification of (15)N-nitrate in urine with gas chromatography combustion isotope ratio mass spectrometry to estimate endogenous NO production. (2010) (7)
- Effect of MARS and PROMETHEUS on systemic hemodynamics and vasoactive agents in patients with acute on-chronic alcoholic liver failure: the clash of the titans (2005) (6)
- Vitamin K and Kidney Transplantation (2020) (6)
- p-Cresol for better or worse: but what are we measuring? (2006) (6)
- Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS (2021) (6)
- Determination of deuterated phenylalanine and tyrosine in egg protein by GCQ (1999) (6)
- Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease. (2016) (6)
- Sclerostin within the Chronic Kidney Disease spectrum. (2019) (6)
- Static HISTOMORPHOMETRY allows for a diagnosis of bone turnover in renal OSTEODYSTROPHY in the absence of tetracycline labels. (2021) (5)
- Early use of cinacalcet (MIMPARA (R)/SENSIPAR (R)) in dialysis patients enables greatest achievement of NKF-KDOQI (TM) treatment targets for bone metabolism (2006) (5)
- Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial (2022) (5)
- A young patient with unexplained acute hepatorenal dysfunction. (2003) (5)
- Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study (2020) (5)
- Clinical case report: a rare cause of acute kidney failure – tissue is the issue (2017) (5)
- Toxic Nephropathy Due to Drugs and Poisons (2010) (5)
- Improving removal of protein-bound retention solutes. (2005) (5)
- Gastric Emptying in Renal Failure Patients Using the 13C-Octanoic Acid Breath Test: Facts and Artifacts (2002) (4)
- Natural History of Bone Disease following Kidney Transplantation (2022) (4)
- CHAPTER 84 – Dermatologic Manifestations of Chronic Kidney Disease (2010) (4)
- Ligand trap for the activin type IIA receptor. The long-sought drug to overcome the calcification paradox in CKD? (2017) (4)
- Early effects of androgen deprivation on bone and mineral homeostasis in adult men: a prospective cohort study. (2020) (4)
- Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk (2021) (4)
- PTH Receptors and Skeletal Resistance to PTH Action (2020) (4)
- Protein bound solutes: Explaining the dissociation between urea-reduction ratio and patient outcome? (2003) (4)
- Study of protein assimilation, using stable isotope techniques. (1998) (3)
- Hemolytic anemia associated with severe hypophosphatemia in a renal transplant recipient (2012) (3)
- Surgical findings and post-operative parathormone levels in patients with secondary hyperparathyroidism. (2009) (3)
- Vascular calcification of the abdominal aorta has minimal impact on lumbar spine bone density in patients with chronic kidney disease. (2022) (3)
- 13C-breath tests in peritoneal dialysis patients: influence of dialysis fluids. (2003) (3)
- The Case | Hypercalcemia in a child with chronic kidney disease. (2016) (3)
- Evidence for malabsorption and increased colonic fermentation of protein, related to gastric acid suppression therapy (1997) (3)
- Chronic kidney disease: Phosphate binder therapy—cracks in the tower of strength? (2012) (3)
- Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence (2022) (3)
- Egg protein assimilation in pancreatic disease studied with a C-13 egg white breath test (1996) (2)
- Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism (2020) (2)
- Coagulation and Fractionated Plasma Separation and Adsorption (2008) (2)
- The influence of chronic kidney disease on the gut microbial metabolism (2014) (2)
- Orocaecal transit time: The lactose-C-13-ureid breath test shows a good correlation with scintigraphy (1997) (2)
- Living Donor Kidney Transplantation: Analysis of the First 40 Cases Performed in UZ Leuven (2008) (2)
- Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges. (2022) (2)
- An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge. (2002) (2)
- Bone health in ageing men (2022) (2)
- Comparison of dialysis efficiency in two different liver detoxification devices: MARS versus Prometheus (2005) (2)
- Nutrition and inflammation (2013) (2)
- Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease (2021) (2)
- European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study (2021) (2)
- Clinical utility of bone turnover markers in patients with chronic kidney disease (2022) (2)
- The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study (2022) (2)
- Comparison of standard and low dose tacrolimus in cadaveric kidney transplant recipients (2001) (2)
- Gastric digestion plays a substantial role in normal protein assimilation (1996) (2)
- 189 Improvement in systemic hemodynamics after mars is associated with a decrease in vasoactive substances in patients with acute on chronic liver failure (AOCLF): Results of a randomised trial (2004) (2)
- Fractionated plasma separation and adsorption in acute-on-chronic liver failure patients results in loss of pro and anticoagulant factors (2007) (2)
- Contemporary kidney transplantation has a limited impact on bone microarchitecture (2022) (2)
- Targeting FGF23 and phosphorus in CKD, do not forget calcium. (2011) (2)
- Response to "tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study on long-term outcomes". (2010) (2)
- Targeting hyperphosphatemia: truth or dare. (2010) (2)
- Spot urine versus 24-hour urine collection for estimation of the generation of uremic toxins originating from gut microbial metabolism. (2020) (2)
- Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism (2022) (1)
- FC 076DIAGNOSTIC ACCURACY OF BONE TURNOVER MARKERS IN RENAL OSTEODYSTROPHY (2021) (1)
- Sclerostin serum levels and vascular calcification in prevalent renal transplant récipients: a longitudinal cohort study (2014) (1)
- Adjuvant low dose cidofovir therapy and reduction of immunosuppression for BK polyomavirus interstitial nephritis (BKVIN) in renal recipients (2005) (1)
- Parathyroid Glands in Chronic Kidney Disease (2020) (1)
- Evaluation of tuberculin skin testing in haemodialysis patients (2002) (1)
- Long-term pharmacokinetic characteristics of the novel combination of tacrolimus and rapamycin in renal transplant recipients (2002) (1)
- Digestibility of raw and cooked egg protein is accurately evaluated by breath test technique (1997) (1)
- POST-STREPTOCOCCAL GLOMERULONEPHRITIS: NOT AN EXTINCT DISEASE! (2013) (1)
- Opinion: When is Vitamin D Contraindicated in Dialysis Patients? (2009) (1)
- CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2 (2014) (1)
- FC 124PATTERNS OF RENAL OSTEODYSTROPHY ONE YEAR AFTER KIDNEY TRANSPLANTATION (2021) (1)
- Acarbose treatment lowers daily generation and serum levels of the protein-bound uremic solute p-cresol: A pilot study (2005) (1)
- Invasive aspergillosis after kidney transplantation: a monocentric retrospective experience (2015) (1)
- Heparin-Coated Hemodialyzers –The Holy Grail for Patients at Risk of Bleeding? (2004) (1)
- Parathyroidectomy Versus Calcimimetic: The Lower the PTH the Better? (2022) (1)
- Pathophysiology and Treatment of Secondary and Tertiary Hyperparathyroidism (2012) (1)
- Direct demonstration of the effect of lactulose on colonic bacterial metabolism by application of lactose-(15N)-ureide (1998) (1)
- Clinical evidence of direct bone effects of cinacalcet. (2020) (1)
- Metabolic and other complications of ESRD - 1 (2009) (1)
- The production of milk and egg proteins, enriched with stable isotopes, for the in vivo study of protein assimilation and metabolism during feeding: an European collaborative study (1998) (1)
- Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients. (2018) (1)
- Cinacalcet (Mimpara (R)/Sensipar (R)) effectively reduces intact parathyroid hormone (iPTH) and serum calcium (Ca) regardless of serum calcium level in patients with secondary hyperparathyroidism (HPT) (2005) (1)
- Discrepancies between bioimpedance spectroscopy devices in haemodialysis patients (2019) (1)
- Endogenous and exogenous protein, escaping digestion and absorption in the small intestine after ingestion of a physiological load of egg protein (1997) (1)
- Exhaled nitric oxide correlates with the activity index of Crohn's disease (CD) and colitis ulcerosa (CU) (1999) (1)
- The Parathyroid Type I Receptor and Vitamin D in Chronic Kidney Disease (2016) (1)
- SP330TOTAL MICROBIAL BURDEN AND ALTERED ENDOGENOUS PHASE 2 METABOLISM DETERMINES THE RELATIONSHIP BETWEEN P-CRESOL AND ADVERSE OUTCOMES IN PATIENTS WITH CKD (2016) (1)
- Mineral metabolism disturbances in kidney donors: smoke, no fire (yet). (2016) (1)
- Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure—A Tri-National Cohort (2022) (1)
- Lactulose causes an important and unpredictable acceleration of the orocaecal transit time (1997) (1)
- The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state (2009) (1)
- Recipientsʼ Smoking Habits and Death-Censored Renal Allograft Survival: 897 (2012) (0)
- Egg protein digestion in normal subjects studied with a (CO2)-C-13 breath test (1996) (0)
- FP604 BONE MINERAL DENSITY, BONE TURNOVER AND PREVALENT AND INCIDENT FRACTURES IN DE NOVO RENAL TRANSPLANT RECIPIENTS (2018) (0)
- P4.3: PHYSICAL ACTIVITY IS ASSOCIATED WITH LOWER ARTERIAL STIFFNESS IN OLDER ADULTS: RESULTS OF THE SAPALDIA 3 COHORT STUDY (0)
- Indications and results of combined liver/kidney transplantation: single center experience (2013) (0)
- Proteinuria, Histology and Kidney-Allograft Survival.: Abstract# 702 (2014) (0)
- Are protein fermentation metabolites involved in the pahogenesis of ulcerative colitis (1998) (0)
- A prospective randomized open-label crossover trial on optimal anticoagulation during liver dialysis by the molecular adsorbents recirculating system (mars) (2010) (0)
- Nephron sparing sugery for renal cell carcinoma in kidney allografts: a retrospective analysis (2016) (0)
- SP331MICROBIOTA DERIVED PHENYLACETYLGLUTAMINE ASSOCIATES WITH SURVIVAL AND CARDIOVASCULAR DISEASE IN PATIENTS WITH CKD (2016) (0)
- Syddansk Universitet Oxidative Stress in Chronic Kidney Disease (2016) (0)
- Mineral metabolism in children with autosomal dominant polycystic kidney disease (2015) (0)
- INFLUENCE OF A HIGH PROTEIN DIET ON THE HUMAN METABOLOME (2014) (0)
- Introduction: Mineral bone disorder is a key player in chronic kidney disease. (2014) (0)
- To evaluate the influence of steroids, we performed a matched-pair analysis of 20 patients in groups A and B with respect to gender, age, weight, and GFR. Group A received (2005) (0)
- Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease across stages of disease (2020) (0)
- High incidence of parathyroidectomy and nephrocalcinosis in renal transplant recipients discontinuing cinacalcet at the time of transplantation (2009) (0)
- Unusual T-cell Repopulation after Autologous Stem Cell Transplantation for HIV-associated Lymphoma (2006) (0)
- Response to Letter to the Editor From Sumi et al: “Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis” (2022) (0)
- PTH control and cardiovascular outcomes: does the treatment approach matter? (2023) (0)
- Effect of exposure of albumin solutions to activated charcoal and ion exchange resin on ligand binding properties and esterase-like activity of albumin (2010) (0)
- PLASMA LEVELS OF ADMA AND SDMA REMAIN STABLE IN INCIDENT PD PATIENTS DESPITE A DECLINING RESIDUAL RENAL FUNCTION: A PROSPECTIVE STUDY (2012) (0)
- Protein assimilation in dialysis patients studied with C-13 breath test technology (2002) (0)
- Microcalcifications in the renal graft are highly prevalent in the early posttransplant period and are related to a disturbed mineral metabolism (2008) (0)
- Crohn's-like pattern in colonic mucosal biopsies in mycophenolate-mofetil treated patients: A link to side effects? (2002) (0)
- DECREASED SERUM SCLEROSTIN LEVELS IN RENAL TRANSPLANT RECIPIENTS WITH PERSISTENT HYPERPARATHYROIDISM: A CROSS-SECTIONAL AND LONGITUDINAL STUDY (2014) (0)
- Combined liver kidney transplantation in the MELD era. Single center analysis (2013) (0)
- Effects of androgen replacement therapy on bone and vascular complications in an adenine-induced CKD rat model (2022) (0)
- SO032BONE AND MINERAL STATUS ONE YEAR AFTER RENAL TRANSPLANTATION (2016) (0)
- A. NUTRITION IN CKD SuO001 HYPOPROTEIC DIET SUPPLEMENTED WITH KETOANALOGUES-EFFECTS ON PROTEINURIA IN PATIENTS WITH DIABETIC KIDNEY DISEASE (2018) (0)
- Dialysis Techniques in the Critic Ally-Ill Patient. (2000) (0)
- Natural history of hyperparathyroidism after successful renal transplantation (2002) (0)
- Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in renal transplant recipients (2009) (0)
- CKD NUTRITION TO017 AST120 IMPROVES INTESTINAL ENVIRONMENT ANDMICROBIOTA IN CKD RATS (2014) (0)
- CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
- Facial Deformity in a Patient with Chronic Secondary Hyperparathyroidism. (2020) (0)
- FP627POOR VITAMIN K STATUS ASSOCIATES WITH LOW AREAL BONE MINERAL DENSITY AND PREDICTS FRACTURES IN DE NOVO RENAL TRANSPLANT RECIPIENTS (2018) (0)
- [OP.1B.01] VITAMIN K DEPENDENT PROTECTION OF RENAL FUNCTION IN MULTI-ETHNIC POPULATION STUDIES (2016) (0)
- MO568STATIC PARAMETERS OF HISTOMORPHOMETRY FOR THE EVALUATION OF BONE TURNOVER IN RENAL OSTEODYSTROPHY (2021) (0)
- S1206 Probiotics Improve the Efficacy of Biofeedback in Patients with Pelvic Floor Dyssynergia (2009) (0)
- Vitamin D in Kidney Transplantation (2016) (0)
- DIALYSIS . BONE DISEASE MO792 CONTEMPORARY MINERAL AND BONE DISORDER MARKERS AND TREATMENT AMONG HEMODIALYSIS PATIENTS IN THE EUROPEAN DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)* Nephrology (2021) (0)
- Colonic fate of malabsorbed egg protein (1998) (0)
- P1388ASSESSING BONE TURNOVER IN CHRONIC KIDNEY DISEASE: SHOULD WE MEASURE NON-OXIDIZED PTH (2020) (0)
- Isolating mineralized bone and bone marrow mRNA from transiliac bone biopsies stored in a stabilizing solution: A comparative study (2022) (0)
- SuO003INDOXYL SULFATE AND P-CRESYL SULFATE PROMOTE VASCULAR CALCIFICATION BY GLUCOSE MEDIATED ACTIVATION OF INFLAMMATION AND COAGULATION PATHWAYS (2018) (0)
- Evaluation of the role of gastric digestion in overall protein assimilation by a combined13C-egg white -14C-octanoic acid breath test (1997) (0)
- Removal of protein bound solutes by convective transport: A randomized cross-over study (2003) (0)
- P1064HEPARIN-FREE DIALYSIS: A PHASE II PILOT STUDY USING ASYMMETRIC TRIACETATE (ATA) CELLULOSE DIALYZERS (2020) (0)
- MO28 CYSTIC FIBROSIS IS ASSOCIATED WITH A DEFECT IN THE RENAL HANDLING OF LOW MOLECULAR WEIGHT PROTEINS (2005) (0)
- Contents Vol. 36, 2012 (2012) (0)
- RENAL DEVELOPMENT AND CYSTIC DISEASES (2013) (0)
- Variants in the Aquaporin-1 gene influence the baseline permeability and the outcome of peritoneal dialysis (2010) (0)
- P4.6: GREATER CAROTID CIRCUMFERENTIAL WALL STRESS IS ASSOCIATED WITH INCIDENT CARDIOVASCULAR DISEASE IN INDIVIDUALS WITH TYPE 2 DIABETES – THE HOORN STUDY (0)
- Inhibition of arterial calcification by matrix Gla protein as determinant of renal function in the general population (2015) (0)
- MO455LIPID PROFILE AND UREMIC RETENTION SOLUTES IN PATIENTS WITH END-STAGE KIDNEY DISEASE (2021) (0)
- Renal transplantation - clinical studies - 1 (2009) (0)
- Indoxyl Sulphate Retention Is Associated with Microvascular Endothelial Dysfunction after Kidney Transplantation (2023) (0)
- Protein assimilation in normal subjects and patients with pancreatic disease, studied with a C-13 egg white breath test (1998) (0)
- An Unusual Case Of Hypercalcemia In A Child With Severe Chronic Kidney Disease (2014) (0)
- SP459DISCREPANCIES OF MEASURED OVERHYDRATION BETWEEN BIOIMPEDANCE SPECTROSCOPY DEVICES IN HD (2018) (0)
- Impact of parathyroidectomy on blood pressure and renal function in renal transplant patients (2002) (0)
- Fractionated plasma separation and adsorption induces fistula thrombosis in maintenance dialysis patients (2007) (0)
- FO003SOLUBLE CD14, A MARKER OF ENDOTOXEMIA, IS ASSOCIATED WITH SURVIVAL AND CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2015) (0)
- COMBINED LIVER AND KIDNEY TRANSPLANTATION: LISTING CRITERIA AND RESULTS (2013) (0)
- Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System: Contribution of the Different Filters Inbuilt (2003) (0)
- Effect of diarrhoea on FK506 versus cyclosporine A through levels and resultant prevention of allograft rejection in renal transplant recipients (2002) (0)
- FP594TARGETING MICROBIOTA DERIVED UREMIC RETENTION SOLUTES WITH ANTIBIOTICS (2015) (0)
- Outcome after nephron sparing surgery for renal cell carcinoma in kidney allografts (2010) (0)
- Early effects of androgen deprivation on bone and mineral homeostasis: A prospective cohort study (2020) (0)
- Reply to: Poor Vitamin K Status in Chronic Kidney Disease: An Indirect Indicator of Hip Fragility (2019) (0)
- Metabolic fate of dietary protein is significantly correlated with renal function (2002) (0)
- Pathophysiology and clinical studies in CKD 5D (2011) (0)
- FP269SOLUBLE CD14, A MARKER OF ENDOTOXEMIA, ASSOCIATES WITH PROGRESSION OF CKD (2015) (0)
- MO044DO WE HAVE EVIDENCE FOR BONE AND MINERAL METABOLISM ALTERATIONS IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (2017) (0)
- The metabolomics grail: promising although not yet holy. (2015) (0)
- CKD BONE DISEASE (2014) (0)
- Polar Views in Nephrology Pro: Cardiovascular calcifications are clinically relevant (2015) (0)
- Chapter 28. Vitamin D: Production, Metabolism, Mechanism of Action, and Clinical Requirements (2008) (0)
- The Dietary Fermentable Fiber Inulin Alters the Intestinal Microbiome and Improves Chronic Kidney Disease Mineral-Bone Disorder in a Rat Model of CKD (2023) (0)
- Erosive enterocolitis in MMF treated renal transplant recipients with persistent afebrile diarrhoea (2002) (0)
- Incidence of posttransplant glycemic disorders in renal transplant recipients treated with low and standard dose tacrolimus (2001) (0)
- Abstracts presented at the 19th Annual Congress of the Belgian Society of Internal Medicine (2014) (0)
- The Clinical Features of Trombotic Microangiopathies Post Transplantation (2014) (0)
- DIALYSIS . BONE DISEASE MO792 CONTEMPORARY MINERAL AND BONE DISORDER MARKERS AND TREATMENT AMONG HEMODIALYSIS PATIENTS IN THE EUROPEAN DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)* WITH A PROSPECTIVE RANDOMIZED TRIAL Nephrology (2021) (0)
- Authorsʼ Reply: Troponin I and Cardiovascular Events in Transplant Patients (2010) (0)
- The intraluminal digestion is a rate limiting step in the assimilation process of egg protein (1997) (0)
- Intra-dialytic removal of p-cresol is not affected by membrane characteristics and convective transport (2002) (0)
- Acknowledgement to Reviewers (2018) (0)
- QTC Interval Duration is Associated with Vascular Calcification in Renal Transplant Candidates (2010) (0)
- Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy (2003) (0)
- Mineral and bone disease - CKD 1-5 (2012) (0)
- Proteinuria, Histology and Kidney-Allograft Survival (2014) (0)
- A curious case of hypercalcemia, hypercalciuria and recurrent nephrolithiases (2018) (0)
- Response to ‘Calcineurin-inhibitors and bone pain after organ transplantation’ (2010) (0)
- Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: A survey of physicians in belgium and the Netherlands (2020) (0)
- Management of fracture risk in CKD—traditional and novel approaches (2022) (0)
- SCLEROSTIN AND DKK-1 LEVELS IN PRE-DIALYISIS CKD PATIENTS (2012) (0)
- MO587: Chronic Kidney Disease Induces Endotoxin-Related Activation of The Innate Immune System (2022) (0)
- Colonic generation of P-cresol is increased in renal failure (2002) (0)
- Fibroblast growth factor 23 and PTH are strong determinants of the bone mineral density changes occuring within the first post-renal transplantation year (2008) (0)
- Epidemiology and CKD - 1 (2009) (0)
- Immunogenicity and safety of influenza trivalent inactivated vaccine in hemodialysis patients and renal transplant recipients (2007) (0)
- Continued improved outcome after simultaneous pancreas kidney transplantation despite low case load (2019) (0)
- Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover (2023) (0)
- Controversy of Dialysate Calcium Concentration (2020) (0)
- A simplified strategy for clinical management of late cytomegalovirus (CMV) infection after oral ganciclovir prophylaxis in de novo renal recipients (2005) (0)
- Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease (2020) (0)
- S1208 Altered Colonic Metabolite Fingerprint in Chronic Kidney Disease As Compared to Healthy State (2009) (0)
- THE IMPACT OF RENAL TRANSPLANTATION ON MICROBIOTA DERIVED UREMIC RETENTION SOLUTES (2014) (0)
- Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients (2019) (0)
- RECIPIENT'S SMOKING HABITS AND DEATH-CENSORED RENAL ALLOGRAFT SURVIVAL (2012) (0)
- BONE AND MINERAL DISEASES-1 SAO014 KAI-4169, A NOVEL PEPTIDE AGONIST OF THE CALCIUM SENSING RECEPTOR, ATTENUATES PTH AND SOFT TISSUE CALCIFICATION AND RESTORES PARATHYROID GLAND VDR LEVELS IN UREMIC RATS (2012) (0)
- Bone and mineral diseases - 1 (2012) (0)
- MO524CALCIMIMETIC ADHERENCE AND PREFERENCE IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN EUROPE: A PILOT STUDY (2021) (0)
- Lower bone turnover and skeletal PTH responsiveness in Japanese compared to European patients on hemodialysis. (2022) (0)
- Elimination of p-cresol in peritoneal dialysis patients (2002) (0)
- Dose-dependent effect of cisapride on orocecal transit studied by the lactose-(13C)-ureide breath test (1998) (0)
- MO792CONTEMPORARY MINERAL AND BONE DISORDER MARKERS AND TREATMENT AMONG HEMODIALYSIS PATIENTS IN THE EUROPEAN DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)* (2021) (0)
- BONE METABOLISM IN CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (2014) (0)
- IS QT INTERVAL A MARKER OF AORTIC CALCIFICATION IN CKD PATIENTS?: 8D.06 (2010) (0)
- independently associated with FGF23 in dialysis patients, transplant recipients and in patients with primary hyper- parathyroidism [5]. It is well known that the dietary ratio of phosphorus to calcium is an important determinant of calcium bioavail- (2011) (0)
- SP691THE SOLUBLE UROKINASE RECEPTOR (SUPAR) PREDICTS MORTALITY IN END-STAGE RENAL DISEASE (2015) (0)
- MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease (2022) (0)
- Persistent Hyperparathyroidism: A Reality Calling for Additional Evidence. (2022) (0)
- Transplantation - clinical II (2012) (0)
- Prediction of new onset diabetes mellitus after transplantation (NODAT): Early evaluation of glucose metabolism (2007) (0)
- Effects of sevelamer hydrochloride (Renagel (R)) and calcium acetate on controlling serum phosphorus in peritonel dialysis patients (2006) (0)
- Is PTH the good target to reduce fractures (2016) (0)
- Dialysis Techniques in the Critic Ally-Ill Patient (2000) (0)
- Transplantation / Clinical studies (2011) (0)
- Food-Derived Uremic Toxins in Chronic Kidney Disease (2023) (0)
- The lactose-(13C)-ureide breath test in combination with the (14C)-octanoate breath test to assess pharmacological modulation by erythromycin and propantheline of proximal gastro-intestinal transit (1998) (0)
- Androgen therapy does not prevent bone loss and arterial calcifications in male rats with CKD. (2023) (0)
- Safety issues related to fractionated plasma separation, adsorption, and dialysis. (2013) (0)
- FP715REMODELING ACTIVTY IS THE MAIN DRIVER OF BONE MINERAL DENSITY CHANGES IN DE NOVO RENAL TRANSPLANT RECIPIENTS (2018) (0)
- Detoxifying capacity and kinetics of the Prometheus system: Contribution of the different filters inbuilt (2005) (0)
- Free serum concentrations of p-cresol as novel cardiovascular risk factor in haemodialysis (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pieter Evenepoel?
Pieter Evenepoel is affiliated with the following schools:
